LV3‐shRNA showed a significant effect in lowering the mean value of body weight, serum creatinine and urinary albumin/creatinine ratio in DN mice (P < 0.05), indicating that down‐regulation of ChemR23 is effective in alleviating DN symptoms. This evidence concerns the gene ALB and liver dysplastic nodule.